In order to test whether the splice variant hEPOΔ3 is also regulated under those pathological conditions, we established a realtime-PCR assay to quantify EPO and hEPOΔ3 transcript levels in human diseased (liver cirrhosis, ccRCC) and normal tissues. Here, EPO is linked to nonpapillary renal cell carcinoma.